<DOC>
	<DOC>NCT00848848</DOC>
	<brief_summary>The study will evaluate the safety, tolerability and immunogenicity of different doses and types of Influenza Vaccine in healthy elderly subjects.</brief_summary>
	<brief_title>Safety, Tolerability, and Immunogenicity of Different Combinations of Trivalent Influenza Vaccine Varying Influenza Antigen Dose, Adjuvant Dose, and Route of Administration in Healthy Elderly Individuals Ages 65 Years and Older</brief_title>
	<detailed_description />
	<mesh_term>Influenza, Human</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Subjects 65 years or older generally in good health as determined by medical history, physical assessment and clinical judgment of the investigator. Subjects who have received influenza vaccine within the past 6 month and who have received adjuvanted vaccine in the past two years. Subjects with hypersensitivity to vaccine components. Subjects who are on or were recently on immunosuppressive therapy.</criteria>
	<gender>All</gender>
	<minimum_age>65 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>Influenza</keyword>
	<keyword>Flu</keyword>
	<keyword>Vaccine</keyword>
	<keyword>Intradermal</keyword>
	<keyword>Adjuvant</keyword>
</DOC>